Raymond James Financial Services Advisors »

Aquestive Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $70k 17k 4.26

More positions owned by Raymond James Financial Services Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Vanguard Index Fds Value Etf (VTV)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Raymond James Financial Services Advisors

Top funds holding Aquestive Therapeutics

Vanguard Group
Essex Investment Management
Vahanian & Associates Financial Planning
Bracebridge Capital
Janney Montgomery Scott
Marshall Wace
Connor, Clark & Lunn Investment Management
Legato Capital Management
Latash Investments
CI Private Wealth
Citadel Advisors
Two Sigma Investments
Jane Street
Millennium Management
Walleye Trading Advisors

View all funds holding Aquestive Therapeutics